Aprutumab ixadotin

DB33805InvestigationalProtein Based Therapies

Aprutumab ixadotin: Overview.

Code names
BAY-1187982

Resolves to

Compound
UNIIDDD2AB5TWKChEMBLCHEMBL4650293

What you can answer from here — as of August 27, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Aprutumab ixadotin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In